

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | blood vessel maturation (GO:0001955) | 6.96746147 |
| 2 | surfactant homeostasis (GO:0043129) | 6.07129564 |
| 3 | regulation of endothelial cell differentiation (GO:0045601) | 5.65734966 |
| 4 | morphogenesis of an endothelium (GO:0003159) | 5.62423583 |
| 5 | endothelial tube morphogenesis (GO:0061154) | 5.62423583 |
| 6 | vascular endothelial growth factor signaling pathway (GO:0038084) | 5.50327332 |
| 7 | lymph vessel development (GO:0001945) | 5.47910482 |
| 8 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 4.78313162 |
| 9 | ovulation from ovarian follicle (GO:0001542) | 4.71172370 |
| 10 | chemical homeostasis within a tissue (GO:0048875) | 4.64137712 |
| 11 | positive regulation of vasculogenesis (GO:2001214) | 4.59734127 |
| 12 | endothelium development (GO:0003158) | 4.51122787 |
| 13 | definitive hemopoiesis (GO:0060216) | 4.49072963 |
| 14 | regulation of vasculogenesis (GO:2001212) | 4.40308314 |
| 15 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 4.38116963 |
| 16 | lymphangiogenesis (GO:0001946) | 4.19696675 |
| 17 | positive regulation of endothelial cell differentiation (GO:0045603) | 4.08298276 |
| 18 | endothelial cell morphogenesis (GO:0001886) | 3.83181912 |
| 19 | glomerular filtration (GO:0003094) | 3.78825943 |
| 20 | renal filtration (GO:0097205) | 3.63763693 |
| 21 | negative regulation of adherens junction organization (GO:1903392) | 3.63332289 |
| 22 | negative regulation of focal adhesion assembly (GO:0051895) | 3.63332289 |
| 23 | negative regulation of cell junction assembly (GO:1901889) | 3.63332289 |
| 24 | phagocytosis, recognition (GO:0006910) | 3.61700076 |
| 25 | venous blood vessel morphogenesis (GO:0048845) | 3.59265477 |
| 26 | positive regulation of receptor recycling (GO:0001921) | 3.48046449 |
| 27 | patterning of blood vessels (GO:0001569) | 3.45483760 |
| 28 | regulation of integrin activation (GO:0033623) | 3.43459023 |
| 29 | ganglion development (GO:0061548) | 3.41690973 |
| 30 | wound healing, spreading of epidermal cells (GO:0035313) | 3.39456239 |
| 31 | protein kinase C signaling (GO:0070528) | 3.38858418 |
| 32 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 3.37472568 |
| 33 | endothelial cell differentiation (GO:0045446) | 3.35595582 |
| 34 | blood vessel remodeling (GO:0001974) | 3.35488722 |
| 35 | regulation of cellular extravasation (GO:0002691) | 3.31260744 |
| 36 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 3.28509060 |
| 37 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 3.26928935 |
| 38 | positive regulation of urine volume (GO:0035810) | 3.24003486 |
| 39 | negative regulation of stress fiber assembly (GO:0051497) | 3.23922430 |
| 40 | nephron epithelium development (GO:0072009) | 3.17152720 |
| 41 | neuron remodeling (GO:0016322) | 3.10158765 |
| 42 | angiogenesis involved in wound healing (GO:0060055) | 3.08762039 |
| 43 | positive regulation of glomerulus development (GO:0090193) | 3.07822526 |
| 44 | substrate-dependent cell migration (GO:0006929) | 3.06746141 |
| 45 | establishment of endothelial barrier (GO:0061028) | 3.06221590 |
| 46 | Notch signaling involved in heart development (GO:0061314) | 3.04771309 |
| 47 | regulation of blood vessel endothelial cell migration (GO:0043535) | 3.03214986 |
| 48 | negative regulation of platelet activation (GO:0010544) | 2.97706651 |
| 49 | megakaryocyte development (GO:0035855) | 2.96368385 |
| 50 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 2.95004399 |
| 51 | negative regulation of DNA biosynthetic process (GO:2000279) | 2.94973871 |
| 52 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 2.94426435 |
| 53 | negative regulation of actin filament bundle assembly (GO:0032232) | 2.93057567 |
| 54 | ovulation (GO:0030728) | 2.91716377 |
| 55 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 2.91687963 |
| 56 | negative regulation of endothelial cell apoptotic process (GO:2000352) | 2.91209848 |
| 57 | regulation of glomerular filtration (GO:0003093) | 2.88776162 |
| 58 | vasculogenesis (GO:0001570) | 2.88235818 |
| 59 | positive regulation of p38MAPK cascade (GO:1900745) | 2.87903930 |
| 60 | cAMP biosynthetic process (GO:0006171) | 2.84581813 |
| 61 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.84438819 |
| 62 | endocrine hormone secretion (GO:0060986) | 2.84398805 |
| 63 | cellular response to epinephrine stimulus (GO:0071872) | 2.84328241 |
| 64 | positive regulation of macrophage cytokine production (GO:0060907) | 2.84033244 |
| 65 | negative regulation of endothelial cell proliferation (GO:0001937) | 2.83962165 |
| 66 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.82881984 |
| 67 | axon extension involved in axon guidance (GO:0048846) | 2.82881984 |
| 68 | negative regulation of endothelial cell migration (GO:0010596) | 2.80776702 |
| 69 | sprouting angiogenesis (GO:0002040) | 2.80469073 |
| 70 | metanephric nephron epithelium development (GO:0072243) | 2.80056766 |
| 71 | regulation of p38MAPK cascade (GO:1900744) | 2.79830779 |
| 72 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.78101935 |
| 73 | ventricular trabecula myocardium morphogenesis (GO:0003222) | 2.76594777 |
| 74 | positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862) | 2.75056698 |
| 75 | fibroblast migration (GO:0010761) | 2.74837020 |
| 76 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.73220808 |
| 77 | basement membrane organization (GO:0071711) | 2.72562466 |
| 78 | apoptotic cell clearance (GO:0043277) | 2.71780157 |
| 79 | regulation of endothelial cell migration (GO:0010594) | 2.70766404 |
| 80 | cellular response to nitric oxide (GO:0071732) | 2.70158186 |
| 81 | cell volume homeostasis (GO:0006884) | 2.70008505 |
| 82 | response to muramyl dipeptide (GO:0032495) | 2.69687120 |
| 83 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.68766308 |
| 84 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.67754251 |
| 85 | negative regulation of fatty acid transport (GO:2000192) | 2.66148118 |
| 86 | regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947) | 2.66046436 |
| 87 | endothelial cell chemotaxis (GO:0035767) | 2.65602558 |
| 88 | heparin biosynthetic process (GO:0030210) | 2.65564414 |
| 89 | heparin metabolic process (GO:0030202) | 2.65564414 |
| 90 | response to fluid shear stress (GO:0034405) | 2.65465749 |
| 91 | muscle filament sliding (GO:0030049) | 2.65222011 |
| 92 | actin-myosin filament sliding (GO:0033275) | 2.65222011 |
| 93 | cardiac myofibril assembly (GO:0055003) | 2.64854755 |
| 94 | adhesion of symbiont to host (GO:0044406) | 2.64782149 |
| 95 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.64518926 |
| 96 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.64518926 |
| 97 | modulation by symbiont of host immune response (GO:0052553) | 2.64518926 |
| 98 | positive regulation by symbiont of host defense response (GO:0052509) | 2.64518926 |
| 99 | modulation by symbiont of host defense response (GO:0052031) | 2.64518926 |
| 100 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.64518926 |
| 101 | positive regulation of endothelial cell migration (GO:0010595) | 2.63718300 |
| 102 | extracellular fibril organization (GO:0043206) | 2.63520467 |
| 103 | heart trabecula formation (GO:0060347) | 2.62851428 |
| 104 | smooth muscle tissue development (GO:0048745) | 2.62188082 |
| 105 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.61919101 |
| 106 | cell migration involved in heart development (GO:0060973) | 2.61712997 |
| 107 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.61368322 |
| 108 | trabecula morphogenesis (GO:0061383) | 2.60709495 |
| 109 | pinocytosis (GO:0006907) | 2.60557907 |
| 110 | myofibril assembly (GO:0030239) | 2.60355583 |
| 111 | secretory granule organization (GO:0033363) | 2.59902803 |
| 112 | mesodermal cell differentiation (GO:0048333) | 2.59588586 |
| 113 | cell-substrate junction assembly (GO:0007044) | 2.59471669 |
| 114 | negative regulation of epithelial cell migration (GO:0010633) | 2.58853952 |
| 115 | cell proliferation involved in metanephros development (GO:0072203) | 2.57505989 |
| 116 | wound healing, spreading of cells (GO:0044319) | 2.57206298 |
| 117 | positive regulation of digestive system process (GO:0060456) | 2.57036992 |
| 118 | sarcomere organization (GO:0045214) | 2.56110409 |
| 119 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.56017683 |
| 120 | semaphorin-plexin signaling pathway (GO:0071526) | 2.55695224 |
| 121 | metanephric epithelium development (GO:0072207) | 2.55027153 |
| 122 | barbed-end actin filament capping (GO:0051016) | 2.54807621 |
| 123 | regulation of platelet activation (GO:0010543) | 2.54719682 |
| 124 | blood circulation (GO:0008015) | 2.54691466 |
| 125 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.54087354 |
| 126 | positive regulation of odontogenesis (GO:0042482) | 2.53519625 |
| 127 | artery development (GO:0060840) | 2.52954694 |
| 128 | atrioventricular valve morphogenesis (GO:0003181) | 2.52806474 |
| 129 | negative regulation of blood vessel morphogenesis (GO:2000181) | 2.52716161 |
| 130 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.52078953 |
| 131 | angiogenesis (GO:0001525) | 2.49581981 |
| 132 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.49283442 |
| 133 | negative regulation of angiogenesis (GO:0016525) | 2.48237611 |
| 134 | endothelial cell proliferation (GO:0001935) | 2.47546254 |
| 135 | regulation of urine volume (GO:0035809) | 2.47543691 |
| 136 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.47397354 |
| 137 | regulation of gamma-delta T cell activation (GO:0046643) | 2.46884614 |
| 138 | coronary vasculature morphogenesis (GO:0060977) | 2.46623629 |
| 139 | response to interferon-alpha (GO:0035455) | 2.46563802 |
| 140 | embryonic placenta development (GO:0001892) | 2.45895453 |
| 141 | negative regulation of protein autophosphorylation (GO:0031953) | 2.45187446 |
| 142 | positive regulation of fibroblast migration (GO:0010763) | 2.44852293 |
| 143 | low-density lipoprotein particle clearance (GO:0034383) | 2.44790501 |
| 144 | positive regulation of adherens junction organization (GO:1903393) | 2.44713460 |
| 145 | polyketide metabolic process (GO:0030638) | 2.44468400 |
| 146 | doxorubicin metabolic process (GO:0044598) | 2.44468400 |
| 147 | daunorubicin metabolic process (GO:0044597) | 2.44468400 |
| 148 | cGMP-mediated signaling (GO:0019934) | 2.42419281 |
| 149 | regulation of macrophage chemotaxis (GO:0010758) | 2.41218454 |
| 150 | embryonic heart tube development (GO:0035050) | 2.41164271 |
| 151 | negative regulation of vasculature development (GO:1901343) | 2.40366782 |
| 152 | regulation of sarcomere organization (GO:0060297) | 2.40227439 |
| 153 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.40062834 |
| 154 | response to epinephrine (GO:0071871) | 2.39127135 |
| 155 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.39051138 |
| 156 | positive regulation of endothelial cell proliferation (GO:0001938) | 2.36280045 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 8.21296009 |
| 2 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 4.15032540 |
| 3 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.25247086 |
| 4 | GATA1_22025678_ChIP-Seq_K562_Human | 3.03156373 |
| 5 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.77922126 |
| 6 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.77922126 |
| 7 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.77922126 |
| 8 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.66094841 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.60579883 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.53199837 |
| 11 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.48286837 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.23473741 |
| 13 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.14457656 |
| 14 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.13859177 |
| 15 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.10871731 |
| 16 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.05214376 |
| 17 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.03448888 |
| 18 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.97257048 |
| 19 | SPI1_23127762_ChIP-Seq_K562_Human | 1.90837589 |
| 20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.90395012 |
| 21 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.89972921 |
| 22 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.88752273 |
| 23 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.88275479 |
| 24 | GATA1_19941826_ChIP-Seq_K562_Human | 1.87903866 |
| 25 | * ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.85984588 |
| 26 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.82333795 |
| 27 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.81569926 |
| 28 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.76558096 |
| 29 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.68919491 |
| 30 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.66463175 |
| 31 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.63739036 |
| 32 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.63579694 |
| 33 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.62632708 |
| 34 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.62229210 |
| 35 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.62229210 |
| 36 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.61419210 |
| 37 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.58595207 |
| 38 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.53836174 |
| 39 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.52747804 |
| 40 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.52092739 |
| 41 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.51806318 |
| 42 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.48881867 |
| 43 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.48859420 |
| 44 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.46582499 |
| 45 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.45684622 |
| 46 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.45106755 |
| 47 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.44177666 |
| 48 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.43860354 |
| 49 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.41398455 |
| 50 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.41176121 |
| 51 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.40951507 |
| 52 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.39998894 |
| 53 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.39577215 |
| 54 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.37404344 |
| 55 | * CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.36258127 |
| 56 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.33118600 |
| 57 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.32644907 |
| 58 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.32644907 |
| 59 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.32618425 |
| 60 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.31789821 |
| 61 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.30572057 |
| 62 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.29190891 |
| 63 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.29049966 |
| 64 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.28482295 |
| 65 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.25732383 |
| 66 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.25092516 |
| 67 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.23873735 |
| 68 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.23315691 |
| 69 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22889014 |
| 70 | GATA2_19941826_ChIP-Seq_K562_Human | 1.22828324 |
| 71 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.20213429 |
| 72 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20161414 |
| 73 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.19706571 |
| 74 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.19108840 |
| 75 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.14613347 |
| 76 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.14027141 |
| 77 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.13715711 |
| 78 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12813279 |
| 79 | CJUN_26792858_Chip-Seq_BT549_Human | 1.12693370 |
| 80 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12253044 |
| 81 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.10234698 |
| 82 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.09713661 |
| 83 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.08936234 |
| 84 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.08784216 |
| 85 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.08442887 |
| 86 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.08219233 |
| 87 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.08195850 |
| 88 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.07839097 |
| 89 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.06964208 |
| 90 | KDM2B_26808549_Chip-Seq_K562_Human | 1.06853194 |
| 91 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.05840943 |
| 92 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.04003995 |
| 93 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.03386793 |
| 94 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.02659596 |
| 95 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.02537537 |
| 96 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.02373842 |
| 97 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.01537085 |
| 98 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.00557611 |
| 99 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.00198252 |
| 100 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99648722 |
| 101 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.98991057 |
| 102 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.98950692 |
| 103 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.98717404 |
| 104 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.98509765 |
| 105 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.98408951 |
| 106 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.98048375 |
| 107 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.95483252 |
| 108 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.94803126 |
| 109 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.94803126 |
| 110 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.94749463 |
| 111 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.94647174 |
| 112 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.94328024 |
| 113 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.93822865 |
| 114 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.92494814 |
| 115 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.92447290 |
| 116 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.91926041 |
| 117 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.91750661 |
| 118 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90793408 |
| 119 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.90643276 |
| 120 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.90252530 |
| 121 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.90215467 |
| 122 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.89823215 |
| 123 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.89253874 |
| 124 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88849197 |
| 125 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.88516225 |
| 126 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.88374100 |
| 127 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.87825604 |
| 128 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.87580203 |
| 129 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.87535943 |
| 130 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.87366770 |
| 131 | MAF_26560356_Chip-Seq_TH1_Human | 0.87204797 |
| 132 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.86553347 |
| 133 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.86148486 |
| 134 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.84184014 |
| 135 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.83832610 |
| 136 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.83617010 |
| 137 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.83339747 |
| 138 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.83230564 |
| 139 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.83230564 |
| 140 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.81840580 |
| 141 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.81811806 |
| 142 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.81610578 |
| 143 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.81583468 |
| 144 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.80665720 |
| 145 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.79717296 |
| 146 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.79700313 |
| 147 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.78664532 |
| 148 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.78495527 |
| 149 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.77993150 |
| 150 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.77958451 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010368_abnormal_lymphatic_system | 6.73310002 |
| 2 | MP0001879_abnormal_lymphatic_vessel | 4.83415924 |
| 3 | * MP0005167_abnormal_blood-brain_barrier | 4.66060290 |
| 4 | MP0003724_increased_susceptibility_to | 3.73589092 |
| 5 | MP0003828_pulmonary_edema | 3.72895116 |
| 6 | MP0004272_abnormal_basement_membrane | 3.19523064 |
| 7 | MP0004084_abnormal_cardiac_muscle | 3.17507857 |
| 8 | MP0009278_abnormal_bone_marrow | 2.79940307 |
| 9 | MP0008438_abnormal_cutaneous_collagen | 2.64945384 |
| 10 | MP0001958_emphysema | 2.62883717 |
| 11 | MP0004510_myositis | 2.59789347 |
| 12 | MP0004782_abnormal_surfactant_physiolog | 2.57178459 |
| 13 | MP0000767_abnormal_smooth_muscle | 2.36050977 |
| 14 | MP0004145_abnormal_muscle_electrophysio | 2.20547259 |
| 15 | MP0005275_abnormal_skin_tensile | 2.14729745 |
| 16 | MP0003566_abnormal_cell_adhesion | 2.12418565 |
| 17 | MP0002138_abnormal_hepatobiliary_system | 2.09672069 |
| 18 | MP0000465_gastrointestinal_hemorrhage | 2.04009962 |
| 19 | MP0002332_abnormal_exercise_endurance | 1.89706185 |
| 20 | MP0005409_darkened_coat_color | 1.80363179 |
| 21 | MP0004036_abnormal_muscle_relaxation | 1.79605192 |
| 22 | MP0006138_congestive_heart_failure | 1.78512641 |
| 23 | MP0005397_hematopoietic_system_phenotyp | 1.72339770 |
| 24 | MP0001545_abnormal_hematopoietic_system | 1.72339770 |
| 25 | MP0009780_abnormal_chondrocyte_physiolo | 1.70607304 |
| 26 | MP0002933_joint_inflammation | 1.70489155 |
| 27 | MP0003279_aneurysm | 1.69903959 |
| 28 | MP0000013_abnormal_adipose_tissue | 1.68502293 |
| 29 | MP0008775_abnormal_heart_ventricle | 1.65051562 |
| 30 | * MP0000249_abnormal_blood_vessel | 1.63991234 |
| 31 | MP0005666_abnormal_adipose_tissue | 1.62114867 |
| 32 | MP0003303_peritoneal_inflammation | 1.59997739 |
| 33 | MP0003191_abnormal_cellular_cholesterol | 1.59504438 |
| 34 | * MP0000343_altered_response_to | 1.58873594 |
| 35 | MP0002108_abnormal_muscle_morphology | 1.52517092 |
| 36 | MP0000569_abnormal_digit_pigmentation | 1.49794689 |
| 37 | MP0005375_adipose_tissue_phenotype | 1.47724606 |
| 38 | MP0005620_abnormal_muscle_contractility | 1.44265545 |
| 39 | MP0001851_eye_inflammation | 1.42098882 |
| 40 | MP0005385_cardiovascular_system_phenoty | 1.39547137 |
| 41 | MP0001544_abnormal_cardiovascular_syste | 1.39547137 |
| 42 | MP0005165_increased_susceptibility_to | 1.38652962 |
| 43 | MP0001835_abnormal_antigen_presentation | 1.36580053 |
| 44 | MP0002925_abnormal_cardiovascular_devel | 1.36201616 |
| 45 | MP0004808_abnormal_hematopoietic_stem | 1.35179623 |
| 46 | MP0010030_abnormal_orbit_morphology | 1.33772055 |
| 47 | MP0005503_abnormal_tendon_morphology | 1.31477346 |
| 48 | MP0003448_altered_tumor_morphology | 1.28932069 |
| 49 | MP0004484_altered_response_of | 1.28205272 |
| 50 | MP0002127_abnormal_cardiovascular_syste | 1.28013329 |
| 51 | MP0003705_abnormal_hypodermis_morpholog | 1.27066617 |
| 52 | * MP0005464_abnormal_platelet_physiology | 1.25815232 |
| 53 | MP0000003_abnormal_adipose_tissue | 1.23429975 |
| 54 | MP0009697_abnormal_copulation | 1.22998451 |
| 55 | * MP0002128_abnormal_blood_circulation | 1.22969980 |
| 56 | MP0000759_abnormal_skeletal_muscle | 1.22324924 |
| 57 | MP0010630_abnormal_cardiac_muscle | 1.22229826 |
| 58 | MP0004233_abnormal_muscle_weight | 1.22214683 |
| 59 | MP0004883_abnormal_blood_vessel | 1.21863844 |
| 60 | MP0001614_abnormal_blood_vessel | 1.21641576 |
| 61 | MP0003091_abnormal_cell_migration | 1.20082410 |
| 62 | MP0005595_abnormal_vascular_smooth | 1.15343476 |
| 63 | MP0005330_cardiomyopathy | 1.15258970 |
| 64 | MP0002254_reproductive_system_inflammat | 1.15248742 |
| 65 | MP0005164_abnormal_response_to | 1.15128751 |
| 66 | MP0004147_increased_porphyrin_level | 1.12887108 |
| 67 | MP0002133_abnormal_respiratory_system | 1.12406014 |
| 68 | MP0005388_respiratory_system_phenotype | 1.12406014 |
| 69 | MP0009785_altered_susceptibility_to | 1.10806029 |
| 70 | MP0004215_abnormal_myocardial_fiber | 1.09980180 |
| 71 | MP0000751_myopathy | 1.09930370 |
| 72 | MP0005075_abnormal_melanosome_morpholog | 1.09021100 |
| 73 | MP0003950_abnormal_plasma_membrane | 1.08057013 |
| 74 | MP0005369_muscle_phenotype | 1.07784657 |
| 75 | MP0002971_abnormal_brown_adipose | 1.07101498 |
| 76 | MP0004085_abnormal_heartbeat | 1.06095464 |
| 77 | MP0002396_abnormal_hematopoietic_system | 1.05722932 |
| 78 | MP0003300_gastrointestinal_ulcer | 1.03724185 |
| 79 | MP0002419_abnormal_innate_immunity | 1.01461819 |
| 80 | MP0003045_fibrosis | 1.00515517 |
| 81 | * MP0005025_abnormal_response_to | 0.98153234 |
| 82 | MP0002972_abnormal_cardiac_muscle | 0.97546965 |
| 83 | MP0002277_abnormal_respiratory_mucosa | 0.96255483 |
| 84 | MP0010352_gastrointestinal_tract_polyps | 0.95310175 |
| 85 | MP0000747_muscle_weakness | 0.94559602 |
| 86 | MP0000750_abnormal_muscle_regeneration | 0.93242669 |
| 87 | MP0009115_abnormal_fat_cell | 0.91647833 |
| 88 | MP0009764_decreased_sensitivity_to | 0.91148650 |
| 89 | MP0002295_abnormal_pulmonary_circulatio | 0.88857220 |
| 90 | MP0000266_abnormal_heart_morphology | 0.88594165 |
| 91 | MP0005174_abnormal_tail_pigmentation | 0.88530637 |
| 92 | MP0005623_abnormal_meninges_morphology | 0.86976207 |
| 93 | MP0001175_abnormal_lung_morphology | 0.86909136 |
| 94 | MP0006054_spinal_hemorrhage | 0.86451503 |
| 95 | MP0003690_abnormal_glial_cell | 0.85938886 |
| 96 | MP0000749_muscle_degeneration | 0.85658319 |
| 97 | MP0001849_ear_inflammation | 0.85385964 |
| 98 | MP0010155_abnormal_intestine_physiology | 0.84696207 |
| 99 | MP0002132_abnormal_respiratory_system | 0.84333096 |
| 100 | MP0002896_abnormal_bone_mineralization | 0.83365495 |
| 101 | MP0002877_abnormal_melanocyte_morpholog | 0.83229522 |
| 102 | MP0004130_abnormal_muscle_cell | 0.83177783 |
| 103 | MP0002405_respiratory_system_inflammati | 0.80449803 |
| 104 | MP0002166_altered_tumor_susceptibility | 0.79930206 |
| 105 | MP0005387_immune_system_phenotype | 0.79128025 |
| 106 | MP0001790_abnormal_immune_system | 0.79128025 |
| 107 | MP0002148_abnormal_hypersensitivity_rea | 0.77550288 |
| 108 | MP0002998_abnormal_bone_remodeling | 0.77327309 |
| 109 | MP0001661_extended_life_span | 0.76705536 |
| 110 | MP0002452_abnormal_antigen_presenting | 0.76560029 |
| 111 | MP0000733_abnormal_muscle_development | 0.75313129 |
| 112 | MP0005670_abnormal_white_adipose | 0.73795371 |
| 113 | MP0008995_early_reproductive_senescence | 0.73436098 |
| 114 | MP0002168_other_aberrant_phenotype | 0.71909647 |
| 115 | MP0003948_abnormal_gas_homeostasis | 0.71078410 |
| 116 | MP0002723_abnormal_immune_serum | 0.70778714 |
| 117 | MP0003646_muscle_fatigue | 0.70670086 |
| 118 | MP0001915_intracranial_hemorrhage | 0.70046929 |
| 119 | MP0003941_abnormal_skin_development | 0.69975123 |
| 120 | MP0003943_abnormal_hepatobiliary_system | 0.68790862 |
| 121 | MP0008004_abnormal_stomach_pH | 0.68276965 |
| 122 | MP0005023_abnormal_wound_healing | 0.68142220 |
| 123 | MP0002269_muscular_atrophy | 0.68066207 |
| 124 | MP0001819_abnormal_immune_cell | 0.66976270 |
| 125 | MP0002106_abnormal_muscle_physiology | 0.66963082 |
| 126 | MP0001853_heart_inflammation | 0.66912173 |
| 127 | MP0003436_decreased_susceptibility_to | 0.66811477 |
| 128 | MP0005508_abnormal_skeleton_morphology | 0.66471006 |
| 129 | MP0001784_abnormal_fluid_regulation | 0.66236259 |
| 130 | MP0000685_abnormal_immune_system | 0.66019097 |
| 131 | MP0002420_abnormal_adaptive_immunity | 0.65772083 |
| 132 | MP0004087_abnormal_muscle_fiber | 0.64802139 |
| 133 | MP0005671_abnormal_response_to | 0.63796511 |
| 134 | MP0000230_abnormal_systemic_arterial | 0.62182398 |
| 135 | MP0003959_abnormal_lean_body | 0.58834525 |
| 136 | MP0003385_abnormal_body_wall | 0.58453815 |
| 137 | MP0004858_abnormal_nervous_system | 0.56657235 |
| 138 | MP0002932_abnormal_joint_morphology | 0.51789109 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hematochezia (HP:0002573) | 6.59823631 |
| 2 | Spontaneous hematomas (HP:0007420) | 6.50109767 |
| 3 | Polycythemia (HP:0001901) | 6.18616532 |
| 4 | Abnormality of the nasal mucosa (HP:0000433) | 5.42153790 |
| 5 | Protrusio acetabuli (HP:0003179) | 5.18891906 |
| 6 | Wrist flexion contracture (HP:0001239) | 4.52734192 |
| 7 | Esophageal varix (HP:0002040) | 4.47656587 |
| 8 | Pulmonary artery stenosis (HP:0004415) | 4.33132878 |
| 9 | Spinal rigidity (HP:0003306) | 4.03611648 |
| 10 | Conjunctival telangiectasia (HP:0000524) | 3.73867824 |
| 11 | Interstitial pulmonary disease (HP:0006530) | 3.64868433 |
| 12 | Portal hypertension (HP:0001409) | 3.62271444 |
| 13 | Increased connective tissue (HP:0009025) | 3.49571846 |
| 14 | Myotonia (HP:0002486) | 3.47916068 |
| 15 | Abnormality of the hepatic vasculature (HP:0006707) | 3.42914728 |
| 16 | Cerebral aneurysm (HP:0004944) | 3.30763081 |
| 17 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.25263973 |
| 18 | Hemangiomatosis (HP:0007461) | 3.13399674 |
| 19 | Visceral angiomatosis (HP:0100761) | 3.12955146 |
| 20 | Orchitis (HP:0100796) | 3.10786661 |
| 21 | Ventricular tachycardia (HP:0004756) | 3.08517156 |
| 22 | Arterial tortuosity (HP:0005116) | 3.05129505 |
| 23 | Overgrowth (HP:0001548) | 3.03284976 |
| 24 | Vascular tortuosity (HP:0004948) | 3.02936455 |
| 25 | Broad metatarsal (HP:0001783) | 3.02000134 |
| 26 | Type 1 muscle fiber predominance (HP:0003803) | 2.92612659 |
| 27 | Atrial fibrillation (HP:0005110) | 2.91620347 |
| 28 | * Prolonged bleeding time (HP:0003010) | 2.87966643 |
| 29 | Aortic aneurysm (HP:0004942) | 2.87414680 |
| 30 | Porencephaly (HP:0002132) | 2.80017176 |
| 31 | Myositis (HP:0100614) | 2.79970793 |
| 32 | Supraventricular arrhythmia (HP:0005115) | 2.77040293 |
| 33 | Difficulty climbing stairs (HP:0003551) | 2.74051281 |
| 34 | Distal lower limb amyotrophy (HP:0008944) | 2.73689090 |
| 35 | Aortic dissection (HP:0002647) | 2.73428113 |
| 36 | Microcytic anemia (HP:0001935) | 2.71806073 |
| 37 | Difficulty running (HP:0009046) | 2.70307925 |
| 38 | Pulmonary hypertension (HP:0002092) | 2.69462184 |
| 39 | Primary atrial arrhythmia (HP:0001692) | 2.67105570 |
| 40 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.65083006 |
| 41 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.62660908 |
| 42 | Bundle branch block (HP:0011710) | 2.62156419 |
| 43 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.59834653 |
| 44 | Hemoptysis (HP:0002105) | 2.59097268 |
| 45 | Cerebral hemorrhage (HP:0001342) | 2.58175325 |
| 46 | Muscle fiber inclusion bodies (HP:0100299) | 2.57939297 |
| 47 | Hip contracture (HP:0003273) | 2.56925422 |
| 48 | EMG: myopathic abnormalities (HP:0003458) | 2.55974858 |
| 49 | Adactyly (HP:0009776) | 2.54055466 |
| 50 | Eczematoid dermatitis (HP:0000976) | 2.53490102 |
| 51 | Supraventricular tachycardia (HP:0004755) | 2.52595585 |
| 52 | Exercise-induced myalgia (HP:0003738) | 2.52038414 |
| 53 | * Epistaxis (HP:0000421) | 2.51582306 |
| 54 | Hemorrhage of the eye (HP:0011885) | 2.49662114 |
| 55 | Aneurysm (HP:0002617) | 2.49100663 |
| 56 | Neonatal death (HP:0003811) | 2.48406972 |
| 57 | Premature rupture of membranes (HP:0001788) | 2.44070180 |
| 58 | Wormian bones (HP:0002645) | 2.43684785 |
| 59 | Nemaline bodies (HP:0003798) | 2.38675221 |
| 60 | Recurrent abscess formation (HP:0002722) | 2.37525451 |
| 61 | Neck muscle weakness (HP:0000467) | 2.35955367 |
| 62 | Abnormality of the calf musculature (HP:0001430) | 2.34415894 |
| 63 | Right ventricular cardiomyopathy (HP:0011663) | 2.33107648 |
| 64 | Ectopia lentis (HP:0001083) | 2.32376846 |
| 65 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.31529827 |
| 66 | Venous insufficiency (HP:0005293) | 2.29264346 |
| 67 | Shallow orbits (HP:0000586) | 2.28724898 |
| 68 | Venous abnormality (HP:0002624) | 2.26861057 |
| 69 | Nonimmune hydrops fetalis (HP:0001790) | 2.23875688 |
| 70 | Lymphangioma (HP:0100764) | 2.23778292 |
| 71 | Gingival bleeding (HP:0000225) | 2.23294019 |
| 72 | Muscle fiber splitting (HP:0003555) | 2.22533904 |
| 73 | Striae distensae (HP:0001065) | 2.21915563 |
| 74 | Amyloidosis (HP:0011034) | 2.19081793 |
| 75 | Complement deficiency (HP:0004431) | 2.18695085 |
| 76 | Pulmonary embolism (HP:0002204) | 2.18625144 |
| 77 | Tetraparesis (HP:0002273) | 2.15912600 |
| 78 | Cervical subluxation (HP:0003308) | 2.15333611 |
| 79 | Distal lower limb muscle weakness (HP:0009053) | 2.15116175 |
| 80 | Limited hip movement (HP:0008800) | 2.15029368 |
| 81 | Acanthosis nigricans (HP:0000956) | 2.14927440 |
| 82 | Absent hand (HP:0004050) | 2.13377075 |
| 83 | Joint contractures involving the joints of the feet (HP:0100492) | 2.11160206 |
| 84 | Flexion contracture of toe (HP:0005830) | 2.11160206 |
| 85 | Dilatation of the ascending aorta (HP:0005111) | 2.09139258 |
| 86 | Oligomenorrhea (HP:0000876) | 2.08503266 |
| 87 | Facial diplegia (HP:0001349) | 2.07667964 |
| 88 | Gingivitis (HP:0000230) | 2.05174495 |
| 89 | Lower limb amyotrophy (HP:0007210) | 2.04316240 |
| 90 | Sudden death (HP:0001699) | 2.03640162 |
| 91 | Stroke (HP:0001297) | 2.03151099 |
| 92 | Abnormality of complement system (HP:0005339) | 2.02691042 |
| 93 | Pigmentary retinal degeneration (HP:0001146) | 2.02393388 |
| 94 | Abnormal platelet volume (HP:0011876) | 2.02003468 |
| 95 | Vertebral clefting (HP:0008428) | 1.99319319 |
| 96 | Scapular winging (HP:0003691) | 1.98942661 |
| 97 | Increased mean platelet volume (HP:0011877) | 1.97416618 |
| 98 | Mucosal telangiectasiae (HP:0100579) | 1.97176213 |
| 99 | Recurrent bacterial skin infections (HP:0005406) | 1.96956585 |
| 100 | Hypoplasia of the iris (HP:0007676) | 1.95318849 |
| 101 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.95267914 |
| 102 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.95116735 |
| 103 | Short 4th metacarpal (HP:0010044) | 1.95116735 |
| 104 | Atrioventricular block (HP:0001678) | 1.94203897 |
| 105 | Optic neuritis (HP:0100653) | 1.93928591 |
| 106 | Retrobulbar optic neuritis (HP:0100654) | 1.93928591 |
| 107 | Hyporeflexia of lower limbs (HP:0002600) | 1.93525053 |
| 108 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.92870231 |
| 109 | Broad face (HP:0000283) | 1.91978039 |
| 110 | Round ear (HP:0100830) | 1.91526781 |
| 111 | Dilated cardiomyopathy (HP:0001644) | 1.90060816 |
| 112 | Abnormal vertebral ossification (HP:0100569) | 1.89960391 |
| 113 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.89635743 |
| 114 | Myocardial infarction (HP:0001658) | 1.88986138 |
| 115 | Bulbar palsy (HP:0001283) | 1.88065124 |
| 116 | Prostate neoplasm (HP:0100787) | 1.87124210 |
| 117 | Systemic lupus erythematosus (HP:0002725) | 1.87053148 |
| 118 | Coxa vara (HP:0002812) | 1.86232883 |
| 119 | Long toe (HP:0010511) | 1.85585486 |
| 120 | Autoimmune thrombocytopenia (HP:0001973) | 1.85521099 |
| 121 | Cellulitis (HP:0100658) | 1.85067972 |
| 122 | Arterial thrombosis (HP:0004420) | 1.84798816 |
| 123 | Skull defect (HP:0001362) | 1.83945802 |
| 124 | Hypertriglyceridemia (HP:0002155) | 1.83531317 |
| 125 | Cerebral ischemia (HP:0002637) | 1.82915836 |
| 126 | Chest pain (HP:0100749) | 1.82106833 |
| 127 | Vertigo (HP:0002321) | 1.81946725 |
| 128 | Hyperactive renin-angiotensin system (HP:0000841) | 1.81434129 |
| 129 | Hyperkalemia (HP:0002153) | 1.81314281 |
| 130 | Abnormality of macrophages (HP:0004311) | 1.80107457 |
| 131 | Abnormality of glycolipid metabolism (HP:0010969) | 1.77957298 |
| 132 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.77957298 |
| 133 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.77957298 |
| 134 | Lipoatrophy (HP:0100578) | 1.77145269 |
| 135 | Purpura (HP:0000979) | 1.76825552 |
| 136 | Nasal polyposis (HP:0100582) | 1.73954784 |
| 137 | Hemiplegia (HP:0002301) | 1.73405389 |
| 138 | Increased cerebral lipofuscin (HP:0011813) | 1.73056646 |
| 139 | Testicular atrophy (HP:0000029) | 1.72710541 |
| 140 | Rectal prolapse (HP:0002035) | 1.72404390 |
| 141 | Annular pancreas (HP:0001734) | 1.71662123 |
| 142 | * Menorrhagia (HP:0000132) | 1.71418263 |
| 143 | Hypochromic microcytic anemia (HP:0004840) | 1.71028470 |
| 144 | Aplasia cutis congenita (HP:0001057) | 1.70189207 |
| 145 | Increased variability in muscle fiber diameter (HP:0003557) | 1.69731878 |
| 146 | Lymphedema (HP:0001004) | 1.69506486 |
| 147 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.68358949 |
| 148 | * Bruising susceptibility (HP:0000978) | 1.68240959 |
| 149 | Emphysema (HP:0002097) | 1.65675862 |
| 150 | Asymmetric septal hypertrophy (HP:0001670) | 1.65666893 |
| 151 | Growth hormone excess (HP:0000845) | 1.63154594 |
| 152 | Petechiae (HP:0000967) | 1.61645630 |
| 153 | Cavernous hemangioma (HP:0001048) | 1.61117958 |
| 154 | Pulmonary infiltrates (HP:0002113) | 1.60714386 |
| 155 | Abnormality of the pulmonary veins (HP:0011718) | 1.60152880 |
| 156 | Heart block (HP:0012722) | 1.58482541 |
| 157 | Abnormal atrioventricular conduction (HP:0005150) | 1.58230314 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TGFBR2 | 4.59574107 |
| 2 | KDR | 3.46704415 |
| 3 | GRK1 | 2.89515134 |
| 4 | RIPK1 | 2.56199592 |
| 5 | TGFBR1 | 2.16740553 |
| 6 | TIE1 | 10.6306919 |
| 7 | CDK12 | 1.98359866 |
| 8 | ERN1 | 1.90951573 |
| 9 | PRKG2 | 1.80386983 |
| 10 | TTN | 1.58137928 |
| 11 | KIT | 1.54412468 |
| 12 | EEF2K | 1.44730257 |
| 13 | PTK2B | 1.23047361 |
| 14 | MAP3K14 | 1.21769746 |
| 15 | MATK | 1.21201518 |
| 16 | MAPKAPK3 | 1.17675909 |
| 17 | MYLK | 1.15118139 |
| 18 | MAPK7 | 1.14530475 |
| 19 | TRIB3 | 1.13955184 |
| 20 | GRK7 | 1.11820706 |
| 21 | NTRK1 | 1.11785168 |
| 22 | GRK5 | 1.10862234 |
| 23 | PTK6 | 1.10009056 |
| 24 | EPHB1 | 1.07307249 |
| 25 | DMPK | 1.03234141 |
| 26 | CSK | 1.02435900 |
| 27 | MAP2K3 | 1.02216683 |
| 28 | CAMK1D | 1.01730631 |
| 29 | IRAK3 | 0.99792709 |
| 30 | PAK4 | 0.97881100 |
| 31 | FGFR3 | 0.96587590 |
| 32 | IKBKE | 0.95428104 |
| 33 | STK24 | 0.94316215 |
| 34 | EPHB2 | 0.94258905 |
| 35 | JAK3 | 0.86556542 |
| 36 | TBK1 | 0.86253665 |
| 37 | TEC | 0.85737702 |
| 38 | LATS2 | 0.85245671 |
| 39 | CSF1R | 0.84463113 |
| 40 | CAMK1G | 0.83365716 |
| 41 | MUSK | 0.83077121 |
| 42 | RPS6KA2 | 0.82261907 |
| 43 | IKBKB | 0.81900585 |
| 44 | CDC42BPA | 0.79481596 |
| 45 | MAP4K1 | 0.79116777 |
| 46 | MAP3K3 | 0.78795655 |
| 47 | TYK2 | 0.77938256 |
| 48 | PKN2 | 0.76147080 |
| 49 | PRKD2 | 0.75448715 |
| 50 | DDR2 | 0.72620456 |
| 51 | PRKD1 | 0.71997870 |
| 52 | NLK | 0.69699107 |
| 53 | MAPK12 | 0.69672993 |
| 54 | CAMK4 | 0.68849357 |
| 55 | ROCK1 | 0.68492766 |
| 56 | HCK | 0.67948779 |
| 57 | ACVR1B | 0.67834582 |
| 58 | MET | 0.67348190 |
| 59 | INSRR | 0.66102704 |
| 60 | STK10 | 0.65185821 |
| 61 | EPHA3 | 0.63804526 |
| 62 | CHUK | 0.63173234 |
| 63 | FGFR4 | 0.62065037 |
| 64 | PRKCH | 0.61659153 |
| 65 | JAK1 | 0.61155942 |
| 66 | PRKAA2 | 0.59884819 |
| 67 | MARK2 | 0.58526784 |
| 68 | PTK2 | 0.58438736 |
| 69 | PDGFRA | 0.57906072 |
| 70 | SGK2 | 0.57716559 |
| 71 | FES | 0.57582152 |
| 72 | ADRBK2 | 0.57489487 |
| 73 | FER | 0.56403573 |
| 74 | HIPK2 | 0.56189004 |
| 75 | ZAP70 | 0.53719439 |
| 76 | ROCK2 | 0.53470729 |
| 77 | PHKG1 | 0.52398677 |
| 78 | PHKG2 | 0.52398677 |
| 79 | PRKD3 | 0.51482244 |
| 80 | ICK | 0.51312005 |
| 81 | TRPM7 | 0.50320711 |
| 82 | PDGFRB | 0.50093447 |
| 83 | IGF1R | 0.48547789 |
| 84 | MAP3K1 | 0.48008375 |
| 85 | MAPK4 | 0.47875338 |
| 86 | RET | 0.47498705 |
| 87 | MAP3K7 | 0.47160004 |
| 88 | JAK2 | 0.46776202 |
| 89 | PAK2 | 0.46560205 |
| 90 | SGK494 | 0.46489768 |
| 91 | SGK223 | 0.46489768 |
| 92 | LRRK2 | 0.45424942 |
| 93 | PDPK1 | 0.44982641 |
| 94 | EGFR | 0.44559241 |
| 95 | IRAK4 | 0.44385208 |
| 96 | TAOK3 | 0.43973276 |
| 97 | SIK2 | 0.42483103 |
| 98 | CAMK1 | 0.41419118 |
| 99 | PRKAA1 | 0.40767348 |
| 100 | MAP3K13 | 0.40387746 |
| 101 | PRPF4B | 0.40257686 |
| 102 | PIK3CA | 0.39985714 |
| 103 | BTK | 0.39093485 |
| 104 | DAPK3 | 0.38651349 |
| 105 | LATS1 | 0.37647101 |
| 106 | PINK1 | 0.36682492 |
| 107 | RPS6KC1 | 0.35561636 |
| 108 | RPS6KL1 | 0.35561636 |
| 109 | GSK3A | 0.34535449 |
| 110 | MAPK15 | 0.34083939 |
| 111 | LMTK2 | 0.33942456 |
| 112 | EPHA2 | 0.33751072 |
| 113 | LCK | 0.33681011 |
| 114 | STK3 | 0.33568964 |
| 115 | NEK9 | 0.32944597 |
| 116 | PDK1 | 0.31422223 |
| 117 | TESK1 | 0.31168228 |
| 118 | PAK6 | 0.30901600 |
| 119 | OBSCN | 0.29990200 |
| 120 | ABL2 | 0.29794764 |
| 121 | WNK1 | 0.29764628 |
| 122 | ITK | 0.29503811 |
| 123 | STK38 | 0.29430829 |
| 124 | SGK3 | 0.28208510 |
| 125 | SRC | 0.27894340 |
| 126 | MARK3 | 0.27124523 |
| 127 | MAP2K1 | 0.26993119 |
| 128 | INSR | 0.26741917 |
| 129 | PKN1 | 0.26334508 |
| 130 | MAP3K6 | 0.26032569 |
| 131 | ABL1 | 0.25715292 |
| 132 | PIM1 | 0.25385636 |
| 133 | CDK8 | 0.25272848 |
| 134 | SMG1 | 0.25222324 |
| 135 | RPS6KA6 | 0.25131134 |
| 136 | CAMK2D | 0.25068427 |
| 137 | EIF2AK2 | 0.23475065 |
| 138 | MTOR | 0.22964921 |
| 139 | GRK6 | 0.22593080 |
| 140 | MOS | 0.21973526 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Malaria_Homo sapiens_hsa05144 | 2.30417163 |
| 2 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 2.06651689 |
| 3 | * ECM-receptor interaction_Homo sapiens_hsa04512 | 2.00507925 |
| 4 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.93987494 |
| 5 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.91441663 |
| 6 | * Platelet activation_Homo sapiens_hsa04611 | 1.79625407 |
| 7 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.78940791 |
| 8 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.78822472 |
| 9 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.78425478 |
| 10 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.75192665 |
| 11 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.68587300 |
| 12 | * Focal adhesion_Homo sapiens_hsa04510 | 1.68381640 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.65603589 |
| 14 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.65455414 |
| 15 | Leishmaniasis_Homo sapiens_hsa05140 | 1.63656164 |
| 16 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.61002153 |
| 17 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.60461381 |
| 18 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.59755339 |
| 19 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.45893644 |
| 20 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.45791590 |
| 21 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.44882643 |
| 22 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.42722540 |
| 23 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.34536748 |
| 24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.32564418 |
| 25 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 1.31017253 |
| 26 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.30111504 |
| 27 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.29669451 |
| 28 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.29173766 |
| 29 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.27713880 |
| 30 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.25016977 |
| 31 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.24700695 |
| 32 | Measles_Homo sapiens_hsa05162 | 1.21223294 |
| 33 | Influenza A_Homo sapiens_hsa05164 | 1.20031152 |
| 34 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.19336777 |
| 35 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.18703922 |
| 36 | Adherens junction_Homo sapiens_hsa04520 | 1.17346237 |
| 37 | Amoebiasis_Homo sapiens_hsa05146 | 1.16811255 |
| 38 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.16795116 |
| 39 | * Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.16172555 |
| 40 | Pertussis_Homo sapiens_hsa05133 | 1.15243829 |
| 41 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.14392842 |
| 42 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.13455104 |
| 43 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.13139672 |
| 44 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.10286589 |
| 45 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.09614056 |
| 46 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.08827116 |
| 47 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.08724553 |
| 48 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.07224725 |
| 49 | Gap junction_Homo sapiens_hsa04540 | 1.06800800 |
| 50 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.05608174 |
| 51 | Apoptosis_Homo sapiens_hsa04210 | 1.04817575 |
| 52 | Salmonella infection_Homo sapiens_hsa05132 | 1.04298400 |
| 53 | Hepatitis C_Homo sapiens_hsa05160 | 1.00989881 |
| 54 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.00147281 |
| 55 | Other glycan degradation_Homo sapiens_hsa00511 | 0.99500805 |
| 56 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.98756236 |
| 57 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.98297256 |
| 58 | * PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.97490012 |
| 59 | Insulin resistance_Homo sapiens_hsa04931 | 0.97412172 |
| 60 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.96785404 |
| 61 | Renin secretion_Homo sapiens_hsa04924 | 0.96003750 |
| 62 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.95775272 |
| 63 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.95408286 |
| 64 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.94996661 |
| 65 | Viral myocarditis_Homo sapiens_hsa05416 | 0.92746919 |
| 66 | Prion diseases_Homo sapiens_hsa05020 | 0.92608237 |
| 67 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.92394635 |
| 68 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.92132071 |
| 69 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.89811396 |
| 70 | Pathways in cancer_Homo sapiens_hsa05200 | 0.89160463 |
| 71 | Axon guidance_Homo sapiens_hsa04360 | 0.88519905 |
| 72 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.87649048 |
| 73 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.86433535 |
| 74 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.86410189 |
| 75 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.86117513 |
| 76 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.85912813 |
| 77 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.85888303 |
| 78 | Circadian rhythm_Homo sapiens_hsa04710 | 0.85640709 |
| 79 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.85400003 |
| 80 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.82774265 |
| 81 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.79601925 |
| 82 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.79015024 |
| 83 | Tuberculosis_Homo sapiens_hsa05152 | 0.78601001 |
| 84 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.78493009 |
| 85 | Legionellosis_Homo sapiens_hsa05134 | 0.78118131 |
| 86 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.76790694 |
| 87 | ABC transporters_Homo sapiens_hsa02010 | 0.76478295 |
| 88 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.74471960 |
| 89 | Lysosome_Homo sapiens_hsa04142 | 0.74272455 |
| 90 | Histidine metabolism_Homo sapiens_hsa00340 | 0.74212951 |
| 91 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.73688864 |
| 92 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.73462102 |
| 93 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.73298915 |
| 94 | Circadian entrainment_Homo sapiens_hsa04713 | 0.73094149 |
| 95 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.72480983 |
| 96 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.71022208 |
| 97 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.70531557 |
| 98 | Melanogenesis_Homo sapiens_hsa04916 | 0.70251837 |
| 99 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.70003624 |
| 100 | Long-term potentiation_Homo sapiens_hsa04720 | 0.69548754 |
| 101 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.69031640 |
| 102 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.66210162 |
| 103 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.65475388 |
| 104 | Bile secretion_Homo sapiens_hsa04976 | 0.65021493 |
| 105 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.64375161 |
| 106 | Salivary secretion_Homo sapiens_hsa04970 | 0.63636738 |
| 107 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.63402422 |
| 108 | Glioma_Homo sapiens_hsa05214 | 0.63396606 |
| 109 | Hepatitis B_Homo sapiens_hsa05161 | 0.62978867 |
| 110 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.61712204 |
| 111 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.59443979 |
| 112 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.59220442 |
| 113 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.58690072 |
| 114 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.58433541 |
| 115 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.58113122 |
| 116 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.56464030 |
| 117 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.56322911 |
| 118 | Shigellosis_Homo sapiens_hsa05131 | 0.55920199 |
| 119 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.55867767 |
| 120 | HTLV-I infection_Homo sapiens_hsa05166 | 0.55778013 |
| 121 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.54656213 |
| 122 | Taste transduction_Homo sapiens_hsa04742 | 0.54260824 |
| 123 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.54236488 |
| 124 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.53998787 |
| 125 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.53679804 |
| 126 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.53480457 |
| 127 | Morphine addiction_Homo sapiens_hsa05032 | 0.52917568 |
| 128 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.52483250 |
| 129 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.52359434 |
| 130 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.52027525 |
| 131 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.51959256 |
| 132 | Phagosome_Homo sapiens_hsa04145 | 0.51745994 |
| 133 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.50961371 |
| 134 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.50489816 |
| 135 | Endocytosis_Homo sapiens_hsa04144 | 0.50402968 |
| 136 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.49794810 |
| 137 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.49679290 |
| 138 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.49067754 |
| 139 | Tight junction_Homo sapiens_hsa04530 | 0.48904401 |
| 140 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.48392728 |
| 141 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.47332059 |
| 142 | Bladder cancer_Homo sapiens_hsa05219 | 0.46346682 |
| 143 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.44364454 |
| 144 | Long-term depression_Homo sapiens_hsa04730 | 0.44279848 |
| 145 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.43132296 |

